Metraipolis › archive › dc_0b8f96cd772f

Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41451985
DOI
10.1128/spectrum.03036-25
License (as archived)
solo-consultazione
Archived
2026-11-07T09:55:43.189Z
SHA-256 of the archived text
7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97
Stable URL of this page
https://metraipolis.com/documento/dc_0b8f96cd772f

How to cite

Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985 — Europe PMC (en), https://europepmc.org/article/MED/41451985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b8f96cd772f (Metraipolis archive dc_0b8f96cd772f, sha256 7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97)
BibTeX
@misc{dc0b8f96cd772f,
  title = {Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types — Europe PMC PMID:41451985},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41451985},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b8f96cd772f; sha256 7c793595ac32365f1380bd315579aab13b089d84f4db930a6ee14bc409ac1d97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451985. Agents can read the archived copy with the MCP tool read_document.